X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
oncology (25) 25
humans (23) 23
breast cancer (19) 19
female (19) 19
index medicus (19) 19
chemotherapy (16) 16
middle aged (16) 16
breast neoplasms - drug therapy (15) 15
adult (13) 13
aged (13) 13
treatment outcome (12) 12
antineoplastic combined chemotherapy protocols - therapeutic use (11) 11
breast neoplasms - pathology (11) 11
cancer (9) 9
disease-free survival (8) 8
antineoplastic combined chemotherapy protocols - adverse effects (7) 7
cancer therapies (7) 7
cyclophosphamide (7) 7
cyclophosphamide - administration & dosage (7) 7
analysis (6) 6
chemotherapy, adjuvant (6) 6
fluorouracil - administration & dosage (6) 6
methotrexate - administration & dosage (6) 6
trastuzumab (6) 6
anthracyclines (5) 5
docetaxel (5) 5
doxorubicin - administration & dosage (5) 5
drug administration schedule (5) 5
drug therapy (5) 5
metastasis (5) 5
paclitaxel - administration & dosage (5) 5
women (5) 5
antineoplastic agents - administration & dosage (4) 4
antineoplastic agents - therapeutic use (4) 4
antineoplastic combined chemotherapy protocols - administration & dosage (4) 4
astrophysics (4) 4
breast neoplasms - mortality (4) 4
care and treatment (4) 4
clinical trials (4) 4
doxorubicin (4) 4
efficacy (4) 4
expression (4) 4
male (4) 4
metastatic breast cancer (4) 4
neoadjuvant therapy (4) 4
paclitaxel (4) 4
research (4) 4
therapy (4) 4
tumors (4) 4
adjuvant treatment (3) 3
aged, 80 and over (3) 3
antimitotic agents (3) 3
antineoplastic agents (3) 3
astrophysics - high energy astrophysical phenomena (3) 3
bevacizumab (3) 3
biopsy (3) 3
breast neoplasms - surgery (3) 3
capecitabine (3) 3
combined modality therapy (3) 3
cyclophosphamide - adverse effects (3) 3
epidermal growth factor (3) 3
estrogen (3) 3
fluorouracil (3) 3
fluorouracil - adverse effects (3) 3
follow-up studies (3) 3
fysik (3) 3
high energy astrophysical phenomena (3) 3
medical prognosis (3) 3
methotrexate (3) 3
mortality (3) 3
multivariate analysis (3) 3
natural sciences (3) 3
naturvetenskap (3) 3
neoadjuvant chemotherapy (3) 3
neoplasm metastasis (3) 3
neoplasm recurrence, local - drug therapy (3) 3
neoplasm staging (3) 3
neutropenia - chemically induced (3) 3
patients (3) 3
pharmacology & pharmacy (3) 3
physical sciences (3) 3
research article (3) 3
taxoids - administration & dosage (3) 3
trial (3) 3
1st-line treatment (2) 2
[phys.astr]physics [physics]/astrophysics [astro-ph] (2) 2
advanced breast cancer (2) 2
angiogenesis (2) 2
animals (2) 2
anthracycline-resistant (2) 2
anthracyclines - pharmacology (2) 2
antibodies, monoclonal - therapeutic use (2) 2
antibodies, monoclonal, humanized - administration & dosage (2) 2
antineoplastic agents - adverse effects (2) 2
antineoplastic agents - pharmacology (2) 2
antitumor-activity (2) 2
aromatase inhibitors (2) 2
biomarkers, tumor - blood (2) 2
breast neoplasms - chemistry (2) 2
breast neoplasms - metabolism (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2010, Volume 375, Issue 9712, pp. 377 - 384
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 6, pp. 640 - 647
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2013, Volume 31, Issue 14, pp. 1719 - 1725
Journal Article
The Lancet Oncology, ISSN 1470-2045, 02/2018, Volume 19, Issue 2, pp. 249 - 256
In the neoadjuvant setting, blockade of HER2 plus use of an aromatase inhibitor in patients with HER2-positive and oestrogen receptor (ER)-positive breast... 
LAPATINIB | TRIAL | WOMEN | MULTICENTER | EFFICACY | ONCOLOGY | SAFETY | ENDOCRINE THERAPY | KI67 | COMBINATION | Antimitotic agents | Medical research | Analysis | Estrogen | Clinical trials | Medicine, Experimental | Breast cancer | Antineoplastic agents
Journal Article
Breast Cancer Research and Treatment, ISSN 0167-6806, 4/2012, Volume 132, Issue 3, pp. 843 - 851
Journal Article
Future Oncology, ISSN 1479-6694, 04/2018, Volume 14, Issue 9, pp. 849 - 859
Aim: Discordance between primary tumor and paired metastases biology has been widely detected in metastatic breast cancer. The aim of this study was to... 
discordance | paired biopsies | metastatic breast cancer | FACTOR RECEPTOR 2 | ESTROGEN-RECEPTOR | CHEMOTHERAPY | TISSUE CONFIRMATION | IMPACT | ONCOLOGY | CARCINOMAS | PROGESTERONE-RECEPTOR | KI67 | DISTANT METASTASES | EXPRESSION
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 12/2005, Volume 11, Issue 24, pp. 8715 - 8721
Journal Article
CANCERS, ISSN 2072-6694, 09/2019, Volume 11, Issue 9, p. 1243
Background: Elevated plasmatic lactate dehydrogenase (LDH) levels are associated with worse prognosis in various malignancies, including metastatic breast... 
CELL LUNG-CANCER | LDH | LACTIC-DEHYDROGENASE | PROGNOSTIC-FACTOR | ONCOLOGY | MARKER | metastatic breast cancer | lactate dehydrogenase | monitoring metastatic breast cancer | serum biomarker
Journal Article
Clinical and Experimental Rheumatology, ISSN 0392-856X, 2015, Volume 33, Issue 4, pp. 449 - 456
Journal Article
Journal Article
Annals of Oncology, ISSN 0923-7534, 12/2018, Volume 29, Issue 12, pp. 2328 - 2333
Abstract Background Chemotherapy plus 1-year trastuzumab is the standard adjuvant treatment of HER2-positive breast cancer. The efficacy of less extended... 
Adjuvant | Breast cancer | De-escalated treatment | Trastuzumab | Cardiac safety | trastuzumab | STAGE BREAST-CANCER | de-escalated treatment | ONCOLOGY | adjuvant | DOXORUBICIN | breast cancer | OPEN-LABEL | DOCETAXEL | cardiac safety | PACLITAXEL
Journal Article
Journal Article
Expert Review of Clinical Pharmacology, ISSN 1751-2433, 03/2014, Volume 8, Issue 2, pp. 251 - 265
Journal Article